Tivicay brochure E

Page 1

Cutterguide: No Printing Process: Offset, GD: ZS 39603

Size: 195 X 125 mm Pages: 16 Colors: C M Y K (4 Colors), Native File: Indesign CC Windows Generated in: Acrobat Distiller XI

Doctors and HIV consultants/nurses can request additional brochures from GSK/ViiV Healthcare. TIVICAY® (dolutegravir) This medicinal product is subject to additional monitoring. Tivicay is used in combination with other antiretroviral medicines to treat adults and adolescents from 12 years of age who are infected with human immunodeficiency virus (HIV). Tivicay must not be given if you are allergic to dolutegravir or any of the excipients in Tivicay or if you are taking dofetilide, a medicine for disturbances of heart rhythm, as it may cause serious side effects. If you believe this is applicable to you - contact your doctor.

Starting with Tivicay (dolutegravir)

Do not drive or operate machinery if you feel dizzy or experience other types of adverse events that can have impact on your ability to drive or operate machinery. Read the package leaflet thoroughly before you use Tivicay. If you want to report an adverse event to any of our medicines or vaccines please contact us by one of the following ways: Web form: se.gsk.com/biverkning Phone: + 46 8 638 93 00 (ask to be connected to Pharmacovigilance) DATE OF PREPARATION: DECEMBER 2015

SE/DLG/0003/15

GSK, BOX 516, 169 29 SOLNA. TFN. 08-638 93 00 SE.GSK.COM, INFO.PRODUKT@GSK.COM TIVICAY is a registered trademark of the ViiV Healthcare Group of Companies. ©2015 ViiV Healthcare group of companies All rights reserved.

SEDLG000315_Tivicay_Brochure_GSKDC-PT-SCD-2015-0385_D2.indd 1-2

PAT I EN T I N F O R M AT I O N

1/19/2016 1:33:54 PM


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.